To View the Complete Catalog

Total Page:16

File Type:pdf, Size:1020Kb

To View the Complete Catalog Product Catalog Private Label - OTC canada 1 Private Label - OTC www.pharmascience.com “Partnership is valuable to us. Our goal is not only to meet but exceed our customers’ expectations.” 2 Summary 1 Allergy Relief 2 Analgesics & Pain Management 3 Stomach Remedies 4 Laxatives 5 Other www.pharmascience.com 3 Desloratadine Allergy Control N ot actual size DESLORATADINE ALLERGY CONTROL is a long-acting antihistamine which provides fast relief from year round allergic symptoms including sneezing, runny nose, itchy nose, congestion, stuffiness, itchy, watery, red eyes, itchy ears, palate, as well as itchy throat and allergic cough. It is also indicated for the fast relief of allergic skin conditions, such as skin itch and hives. DESLORATADINE ALLERGY CONTROL does not cause drowsiness. Product Features Medicinal Ingredient Non-Medicinal Ingredients FD&C Blue No. 2 Aluminum Lake, Hypromellose, Lactose, Desloratadine 5 mg Magnesium Oxide, Microcrystalline Cellulose, Polyethylene Glycol, Pregelatinized Starch, Titanium Dioxide, Zinc Stearate DIN/NPN Format National Brand Shelf Life Available in blister DIN 02298155 36 Months sleeves of 10 tablets AERIUS® Scheduling by Province National (excluding Quebec) Quebec Unscheduled for adult use Annex 3 Source: www.napra.ca, www.opq.org, www.nlpb.ca, www.pharmacists.ab.ca/nCollege/default.aspx, www.bcpharmacists.org Aerius ® is a registered trademark of Schering-Plough Canada Inc. Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montreal (QC), Canada H4P 2T4 www.pharmascience.com 4 Extra Strength Allergy Relief N ot actual size EXTRA STRENGTH ALLERGY RELIEF can start to work in 20 minutes PLUS lasts 24 hours providing relief of sneezing, runny nose, stuffiness, nasal congestion, itchy, watery eyes, itchy nose and throat, post-nasal discharge, allergic skin itch and hives. Prolonged use only as directed by a doctor. Product Features Medicinal Ingredient Non-Medicinal Ingredients Corn Starch, Hypromellose, Lactose, Magnesium Stearate, Cetirizine Hydrochloride 10 mg Polyethylene Glycol, Povidone, Titanium Dioxide DIN/NPN Format National Brand Shelf Life Available in blister sleeves DIN 02315955 36 Months of 10 or 12 tablets REACTINE® Scheduling by Province National (excluding Quebec) Quebec Unscheduled Annex 3 Source: www.napra.ca, www.opq.org, www.nlpb.ca, www.pharmacists.ab.ca/nCollege/default.aspx, www.bcpharmacists.org Reactine ® is a registered trademark of Mcneil Consumer Healthcare, Division of Johnson & Johnson Inc. Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montreal (QC), Canada H4P 2T4 www.pharmascience.com 5 ASA 81 mg Enteric Coated N ot actual size ASA 81 mg is for physician-supervised, long-term preventative therapy in adults. Product Features Medicinal Ingredient Non-Medicinal Ingredients Colloidal Silicon Dioxide, Lactose, Methacrylic Acid Copolymer Type C, Methylated Silica, Methylcellulose, Polydimethylsiloxane, Polyethylene Glycol, Acetylsalicylic Acid (ASA) 81 mg Pregelatinized Starch, Sodium Bicarbonate, Sodium Lauryl Sulphate, Sorbitan Tristearate, Stearic Acid, Talc, Titanium Dioxide, Triethyl Citrate DIN/NPN Format National Brand Shelf Life Available in a bottle format with child-resistant cap or DIN 02244993 36 Months easy open cap in quantities from 30-500 tablets ASPIRIN® Scheduling by Province National Quebec Alberta (excluding Quebec & Alberta) Schedule 3 Annex 3 UNSCHEDULED Source: www.napra.ca, www.opq.org, www.nlpb.ca, www.pharmacists.ab.ca/nCollege/default.aspx, www.bcpharmacists.org Aspirin ® is a registered trademark of Bayer Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montreal (QC), Canada H4P 2T4 www.pharmascience.com 6 ASA 81 mg Chewable N ot actual size ASA 81 mg is for physician-supervised, long-term preventative therapy in adults. Product Features Medicinal Ingredient Non-Medicinal Ingredients Acetylsalicylic Acid (ASA) 81 mg D&C Yellow No. 10, FD&C Red No. 40, Mannitol, Orange Flavour, Orange Flavour Pregelatinized Starch, Sodium Saccharin, Stearic Acid DIN/NPN Format National Brand Shelf Life Available in a bottle format DIN 02304651 with child-resistant cap 24 Months from 30-120 tablets ASPIRIN® Scheduling by Province National Quebec Alberta (excluding Quebec & Alberta) Schedule 3 Annex 3 UNSCHEDULED Source: www.napra.ca, www.opq.org, www.nlpb.ca, www.pharmacists.ab.ca/nCollege/default.aspx, www.bcpharmacists.org Aspirin ® is a registered trademark of Bayer Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montreal (QC), Canada H4P 2T4 www.pharmascience.com 7 Naproxen N ot actual size Trust NAPROXEN for providing fast and effective relief of pain such as arthritis pain and pain of inflammation. NAPROXEN relieves arthritic conditions such as stiffness, pain experienced day or night due to arthritis or stiffness of rheumatic conditions. NAPROXEN also relieves joint and body pain, muscular ache, muscle sprains and strains, backache, minor aches, headaches, migraine pain, menstrual cramps, pain of minor surgery, toothaches, pain of dental extractions, pain associated with the common cold and reduces fever. Clinical studies show long lasting relief for up to 12 hours. Product Features Medicinal Ingredient Non-Medicinal Ingredients FD&C Blue No.2 Aluminum Lake, Hypromellose, Maize Starch, Naproxen Sodium 220 mg Microcrystalline Cellulose, Polyethylene Glycol, Povidone, Sodium Starch Glycolate, Stearic Acid, Titanium Dioxide DIN/NPN Format National Brand Shelf Life Available in a bottle format DIN 02362430 with child-resistant cap 36 Months from 24-250 caplets ALEVE® Scheduling by Province National (excluding Quebec) Quebec Unscheduled in package sizes of up to 6,600 mg OR 30 CAPLETS. Annex 2 Schedule 3 in package sizes exceeding 6,600 mg OR 3O CAPLETS Source: www.napra.ca, www.opq.org, www.nlpb.ca, www.pharmacists.ab.ca/nCollege/default.aspx, www.bcpharmacists.org Aleve ® is a registered trademark of Bayer Inc. Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montreal (QC), Canada H4P 2T4 www.pharmascience.com 8 Ibuprofen 200 mg N N ot actual size ot actual size For fast and effective relief of headaches, menstrual pain, toothache (dental pain), backache, pain from inflammation associated with arthritis, minor aches and pains in muscles, bones and joints and reduction of fever. Product Features Medicinal Ingredient Non-Medicinal Ingredients Colloidal Sillicon Dioxide, Dextrose Monohydrate, Hypromellose, Iron Oxide Red, Lactose Monohydrate, Lecithin, Maltodextrin, Povidone, Pregelatinized Starch, Ibuprofen 200 mg Sodium Carboxymethylcellulose, Sodium Starch Glycolate, Starch, Stearic Acid, Titanium Dioxide, Triacetin DIN/NPN Format National Brand Shelf Life Available in a bottle DIN 02314762 (caplet) format with child-resistant 48 Months DIN 02314754 (tablet) cap from 24-250 tablets or caplets ADVIL® Scheduling by Province National (excluding Quebec) Quebec UNSCHEDULED (when sold in package sizes of up to 18,000 mg or 90 pills) Annex 3 Schedule 3 (when sold in pack sizes exceeding 18,000 mg or 90 pills) Source: www.napra.ca, www.opq.org, www.nlpb.ca, www.pharmacists.ab.ca/nCollege/default.aspx, www.bcpharmacists.org Advil ® is a registered trademark of Wyeth Consumer Healthcare Inc. Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montreal (QC), Canada H4P 2T4 www.pharmascience.com 9 Extra Strength Ibuprofen N ot actual size 400 mg For fast and effective relief of headaches, menstrual pain, toothache (dental pain), backache, pain from inflammation associated with arthritis, minor aches and pains in muscles, bones and joints and reduction of fever. Product Features Medicinal Ingredient Non-Medicinal Ingredients Colloidal Sillicon Dioxide, Dextrose Monohydrate, Hypromellose, Iron Oxide Red, Lactose Monohydrate, Lecithin, Maltodextrin, Povidone, Pregelatinized Starch, Ibuprofen 400 mg Sodium Carboxymethylcellulose, Sodium Starch Glycolate, Starch, Stearic Acid, Titanium Dioxide, Triacetin DIN/NPN Format National Brand Shelf Life Available in a bottle format with child-resistant DIN 02314770 48 Months or easy open cap from 16-144 caplets ADVIL® Scheduling by Province National (excluding Quebec) Quebec UNSCHEDULED (when sold in package sizes of up to 18,000 mg or 45 pills) Annex 2 Schedule 3 (when sold in pack sizes exceeding 18,000 mg or 45 pills) Source: www.napra.ca, www.opq.org, www.nlpb.ca, www.pharmacists.ab.ca/nCollege/default.aspx, www.bcpharmacists.org Advil ® is a registered trademark of Wyeth Consumer Healthcare Inc. Pharmascience Inc., 6111, Royalmount Avenue, Suite 100, Montreal (QC), Canada H4P 2T4 www.pharmascience.com 10 Ibuprofen Muscle and Joint N ot actual size For fast and effective relief of pains in muscles, bones and joints; also indicated for headaches, menstrual pain, dental pain, backache, pain from inflammation associated with arthritis, minor aches, and reduction of fever. Product Features Medicinal Ingredient Non-Medicinal Ingredients Colloidal Sillicon Dioxide, Dextrose Monohydrate, Hypromellose, Iron Oxide Red, Lactose Monohydrate, Lecithin, Maltodextrin, Povidone, Pregelatinized Starch, Ibuprofen 400 mg Sodium Carboxymethylcellulose, Sodium Starch Glycolate, Starch, Stearic Acid, Titanium Dioxide, Triacetin DIN/NPN Format National Brand Shelf Life Available in bottled formats DIN 02377101 48 Months of 32, 40, 72 and 84 Caplets ADVIL® Scheduling by Province National (excluding Quebec) Quebec UNSCHEDULED (when sold in package sizes of up to 18,000 mg or 45 pills) Annex 2 Schedule 3 (when sold in pack sizes exceeding 18,000 mg or 45 pills) Source: www.napra.ca, www.opq.org, www.nlpb.ca,
Recommended publications
  • Church & Dwight Annual Report 2020
    Church & Dwight Annual Report 2020 Form 10-K (NYSE:CHD) Published: February 18th, 2020 PDF generated by stocklight.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10585 CHURCH & DWIGHT CO., INC. (Exact name of registrant as specified in its charter) Delaware 13-4996950 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 500 Charles Ewing Boulevard, Ewing, NJ 08628 (Address of principal executive offices) Registrant’s telephone number, including area code: (609) 806-1200 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Name of each exchange Symbol(s) on which registered Common Stock, $1 par value CHD New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • 2019 Annual Report
    church & dwight co., inc. Annual Report 2019 In Millions, except per share data 2019 2018 reportedadjusted* reported net sales $ 4,358 $ 4,358 $ 4,146 gross profit margin 45.5 % 45.5 % 44.4% income from operations $ 840 $ 851 $ 792 operating profit margin 19.3 % 19.5 % 19.1% net income $ 616 $ 624 $ 569 net income per share—diluted $ 2.44 $ 2.47 $ 2.27 dividends per share $ 0.91 $ 0.91 $ 0.87 year-end stock price $ 70.35 $ 70.35 $ 65.76 On January 31, 2020, the Company declared a 5.5% increase in its quarterly dividend from $0.2275 per share to $0.24 per share. 2019 key financial results – Worldwide net sales increased 5.1%. – Organic sales increased 4.4%. – Gross profit margin increased 110 basis points to 45.5%. – Adjusted operating profit margin increased 40 basis points to 19.5%. – Net cash from operations increased to a record level of $864.5 million. – Adjusted earnings per share increased 8.8%. net sales earnings per share (in millions of dollars) (in dollars) $2.47(2) $2.27 $4,146 $4,358 $3,776 $1.94(1) 2017 2018 2019 2017 2018 2019 For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. * This annual report includes non-GAAP financial measures, including adjusted income from operations, adjusted operating profit margin, adjusted net income, adjusted EPS, organic sales, and free cash flow, which differ from reported results using Generally Accepted Accounting Principles (GAAP).
    [Show full text]
  • Vividata Brands by Category
    Brand List 1 Table of Contents Television 3-9 Radio/Audio 9-13 Internet 13 Websites/Apps 13-15 Digital Devices/Mobile Phone 15-16 Visit to Union Station, Yonge Dundas 16 Finance 16-20 Personal Care, Health & Beauty Aids 20-28 Cosmetics, Women’s Products 29-30 Automotive 31-35 Travel, Uber, NFL 36-39 Leisure, Restaurants, lotteries 39-41 Real Estate, Home Improvements 41-43 Apparel, Shopping, Retail 43-47 Home Electronics (Video Game Systems & Batteries) 47-48 Groceries 48-54 Candy, Snacks 54-59 Beverages 60-61 Alcohol 61-67 HH Products, Pets 67-70 Children’s Products 70 Note: ($) – These brands are available for analysis at an additional cost. 2 TELEVISION – “Paid” • Extreme Sports Service Provider “$” • Figure Skating • Bell TV • CFL Football-Regular Season • Bell Fibe • CFL Football-Playoffs • Bell Satellite TV • NFL Football-Regular Season • Cogeco • NFL Football-Playoffs • Eastlink • Golf • Rogers • Minor Hockey League • Shaw Cable • NHL Hockey-Regular Season • Shaw Direct • NHL Hockey-Playoffs • TELUS • Mixed Martial Arts • Videotron • Poker • Other (e.g. Netflix, CraveTV, etc.) • Rugby Online Viewing (TV/Video) “$” • Skiing/Ski-Jumping/Snowboarding • Crave TV • Soccer-European • Illico • Soccer-Major League • iTunes/Apple TV • Tennis • Netflix • Wrestling-Professional • TV/Video on Demand Binge Watching • YouTube TV Channels - English • Vimeo • ABC Spark TELEVISION – “Unpaid” • Action Sports Type Watched In Season • Animal Planet • Auto Racing-NASCAR Races • BBC Canada • Auto Racing-Formula 1 Races • BNN Business News Network • Auto
    [Show full text]
  • Church & Dwight Co, Inc. 2016 Annual Report
    2016 Annual Report CHURCH & DWIGHT CO., INC. ® 55352c1.indd 1 3/22/17 2:36 PM 2016 Annual Report KEY FINANCIAL HIGHLIGHTS In Millions, except per share data 2015 2016 reported adjusted* reported adjusted* NET SALES $ 3,395 $ 3,395 $ 3,493 $ 3,493 GROSS PROFIT MARGIN 44.5 % 44.5 % 45.5 % 45.7 %(2) INCOME FROM OPERATIONS $ 674 $ 683 $ 724 $ 729 (3) OPERATING PROFIT MARGIN 19.9 % 20.1 % 20.7 % 20.9 %(3) NET INCOME $ 410 $ 434 $ 459 $ 464 (4) NET INCOME PER SHARE — DILUTED $ 1.54 $ 1.62 $ 1.75 $ 1.77 (4) DIVIDENDS PER SHARE $ 0.67 $ 0.67 $ 0.71 $ 0.71 YEAR-END STOCK PRICE $ 42.44 $ 42.44 $ 44.19 $ 44.19 2016 Key Financial Results On February 7, 2017, the Company • Worldwide net sales increased 2.9%. declared a 7% increase in its quarterly • Organic sales increased 3.2%. (1) dividend from $0.1775 per share to • Adjusted gross profi t margin increased 120 basis points to 45.7%. $0.19 per share. • Adjusted operating profi t margin increased 80 basis points to 20.9%. • Net cash from operations increased to a record level of $655 million. • Adjusted earnings per share increased 9.3%. Net sales Earnings per share (in millions of dollars) (in dollars) 2014 2014 2015 2016 $3,298 $1.51 2015 $3,395 $1.62 (4) 2016 $3,493 $1.77 (4) For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.
    [Show full text]
  • Church & Dwight
    Church & Dwight Company, Inc. Annual Report 2019 Form 10-K (NYSE:CHD) Published: February 21st, 2019 PDF generated by stocklight.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Commission file number 1-10585 CHURCH & DWIGHT CO., INC. (Exact name of registrant as specified in its charter) Delaware 13-4996950 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 500 Charles Ewing Boulevard, Ewing, N.J. 08628 (Address of principal executive offices) Registrant’s telephone number, including area code: (609) 806-1200 Securities registered pursuant to Section 12(b) of the Act: Name of each exchange Title of each class on which registered Common Stock, $1 par value New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act :None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • 2016 Annual Report CHURCH & DWIGHT CO., INC
    2016 Annual Report CHURCH & DWIGHT CO., INC. ® 55352c1.indd 1 3/22/17 2:36 PM 2016 Annual Report KEY FINANCIAL HIGHLIGHTS In Millions, except per share data 2015 2016 reported adjusted* reported adjusted* NET SALES $ 3,395 $ 3,395 $ 3,493 $ 3,493 GROSS PROFIT MARGIN 44.5 % 44.5 % 45.5 % 45.7 %(2) INCOME FROM OPERATIONS $ 674 $ 683 $ 724 $ 729 (3) OPERATING PROFIT MARGIN 19.9 % 20.1 % 20.7 % 20.9 %(3) NET INCOME $ 410 $ 434 $ 459 $ 464 (4) NET INCOME PER SHARE — DILUTED $ 1.54 $ 1.62 $ 1.75 $ 1.77 (4) DIVIDENDS PER SHARE $ 0.67 $ 0.67 $ 0.71 $ 0.71 YEAR-END STOCK PRICE $ 42.44 $ 42.44 $ 44.19 $ 44.19 2016 Key Financial Results On February 7, 2017, the Company • Worldwide net sales increased 2.9%. declared a 7% increase in its quarterly • Organic sales increased 3.2%. (1) dividend from $0.1775 per share to • Adjusted gross profi t margin increased 120 basis points to 45.7%. $0.19 per share. • Adjusted operating profi t margin increased 80 basis points to 20.9%. • Net cash from operations increased to a record level of $655 million. • Adjusted earnings per share increased 9.3%. Net sales Earnings per share (in millions of dollars) (in dollars) 2014 2014 2015 2016 $3,298 $1.51 2015 $3,395 $1.62 (4) 2016 $3,493 $1.77 (4) For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.
    [Show full text]
  • Lijst OTC-Geneesmiddelen 2019 Geldig T/M 31 December 2020
    Lijst OTC-Geneesmiddelen 2019 Geldig t/m 31 december 2020 NAAM GENEESMIDDEL FABRIEK LAND HERKOMST LEVERANCIER GENERIEK Acetylcysteine Apotex bruistabletten 200 mg 20 stuks Apotex Europe BV Nederland The Eighth Continent acetylcysteine Acetylcysteine Teva bruistabletten 200mg 2x15 stuks Teva Nederland B.V. Nederland Visser Trading acetylcysteine Aciclovir HTP koortslip creme 50mg/g 3 gram Healthypharm Nederland Global Trading aciclovir Advil Liqui-Gels Liquid filled capsules 200mg 50 x 2 stuks Pfizer U.S.A. Romar Trading ibuprofen Advil tablets 200mg 50 x 2 stuks Pfizer U.S.A. Romar Trading ibuprofen Alka Seltzer effervescent tablets 12 stuks Bayer S.A. Guatemala El Louvre NV sodium bicarbonate, citric acid, acetylsalicylic acid AM/PM Menopause Formula tablets 30 stuks + 30 stuks Enzymatic Therapy, Inc. U.S.A. Charnel NV AM:green tea, panax ginseng, black cohosh, PM:valerian, hops, l-theanine, black cohosh Andrews Original sparkling salt sachets 12 stuks GSK Costa Rica Aventa Aruba sodium bicarbonate, magnesium sulfate Aramol liquid 160mg/5ml 125ml Carlisle Laboratories Ltd. Barbados Martijn Trading paracetamol Arniflora Arnica gel 1oz. Nature's Way/B & T U.S.A. Charnel NV arnica montana 1X hpus Arniflora Arnica gel 2.75oz. Nature's Way/B & T U.S.A. Charnel NV arnica montana 1X hpus Aveeno Active Naturals Anti-Itch concentrated lotion 4fl.oz.(118ml) Johnson & Johnson Consumer U.S.A. Manrique Capriles calamine, pramoxine HCl Aveeno Baby Eczema Therapy Moisturizing cream 5 oz.(141g) Johnson & Johnson Consumer Inc. U.S.A. Manrique Capriles colloidal oatmeal Aveeno Baby Eczema Therapy Moisturizing cream 7.3 oz.(206g) Johnson & Johnson Consumer Inc.
    [Show full text]
  • Church & Dwight Annual Report 2021
    Church & Dwight Annual Report 2021 Form 10-K (NYSE:CHD) Published: February 18th, 2021 PDF generated by stocklight.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-10585 CHURCH & DWIGHT CO., INC. (Exact name of registrant as specified in its charter) Delaware 13-4996950 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 500 Charles Ewing Boulevard, Ewing, NJ 08628 (Address of principal executive offices) Registrant’s telephone number, including area code: (609) 806-1200 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Name of each exchange Symbol(s) on which registered Common Stock, $1 par value CHD New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Customer Price Catalog by Dept. & Category
    Customer Price Catalog By Dept. & Category Department: 0 to 9999 For full price listing, contact 1-800-665-6190 Category: 1 to 999000 Case Code Unit Code Description Pack Size Status Department: 1 GROCERY Category: 1 KETCHUP 668913 ++KETCHUP SQUEEZE(12) HARMONIE12 1 LT $0.00 $0.00 285718 KETCHUP 26ML MEGAPAK HEINZ1 396 PK $0.00 $0.00 636506 KETCHUP BIG RED JUG HEINZ (2)2 2.84 LT $0.00 $0.00 830828 KETCHUP BOTTLES FS (GLASS) HEINZ1 24x375 ML $0.00 $0.00 SP 494500 KETCHUP FS UPSIDE DOWN SQZ (24) HEINZ24 375 ML $0.00 $0.00 885483 KETCHUP JUG WINGS2 4 LT $0.00 $0.00 142240 KETCHUP ORGANIC EASY SQUEEZE HEINZ1 750 ML $0.00 $0.00 SP 823179 KETCHUP PORTIONS 8 ML HEINZ1 1000 PK $0.00 $0.00 868257 KETCHUP PORTIONS 8ML HEINZ1 500 PK $0.00 $0.00 SP 859744 KETCHUP PORTIONS 9GR PC WINGS1 500 PK $0.00 $0.00 488296 KETCHUP SQUEEZE HEINZ12 1 LT $0.00 $0.00 352153 KETCHUP TINS HEINZ1 6x2.84 LT $0.00 $0.00 SP 277947 KETCHUP UPSIDE DOWN EASY SQZ (12) HEINZ12 750 ML $0.00 $0.00 996702 KETCHUP UPSIDE DOWN FOODSERVICE (20) HEINZ20 575 ML $0.00 $0.00 772475 KETCHUP UPSIDE DOWN RETAIL EASY SQZ HEINZ1 12x375 ML $0.00 $0.00 SP 886499 KETCHUP VOL PAK HEINZ1 11.3 LT $0.00 $0.00 762716 KETCHUP VOL PAK PC WINGS1 11.3 LT $0.00 $0.00 2421261 PUMP FOR 4LT KETCHUP MUSTARD1 EACH $0.00 $0.00 364927 PUMPS FOR BIG RED JUGS HEINZ1 1 EA $0.00 $0.00 671016 VOL PAK DISPENSOR SPIGOT WINGS1 1 EA $0.00 $0.00 Category: 5 TOMATO SAUCE/PASTE/PUREE 341800 SAUCE MANWICH HUNTS1 398 ML $0.00 $0.00 SP 435750 SAUCE PASTA HEINZ1 6x2.84 LT $0.00 $0.00 SP 372599 SAUCE PASTA PRIMO6 2.84 LT $0.00
    [Show full text]
  • Church & Dwight Co., Inc
    ANNUAL REPORT CHURCH & DWIGHT CO., INC. — 2020 IN MILLIONS, EXCEPT PER SHARE DATA 2020 2019 reportedadjusted* reported adjusted* Net Sales $ 4,896 $ 4,896 $ 4,358 $ 4,358 Gross Profit Margin 45.2 % 45.2 % 45.5 % 45.5 % Income from Operations $ 1,030 $ 933 $ 840 $ 851 Operating Profit Margin 21.0 % 19.0 % 19.3 % 19.5 % Net Income $ 786 $ 713 $ 616 $ 624 Net Income Per Share—Diluted $ 3.12 $ 2.83 $ 2.44 $ 2.47 Dividends Per Share $ 0.96 $ 0.96 $ 0.91 $ 0.91 Year-end Stock Price $ 87.23 $ 87.23 $ 70.35 $ 70.35 On January 29, 2021, the Company declared a 5.2% increase in its quarterly dividend from $0.24 per share to $0.2525 per share. 2020 Key Financial Results – Worldwide net sales increased 12.3%. – Organic sales increased 9.6%. – Gross profit margin decreased 30 basis points to 45.2%. – Adjusted operating profit margin decreased 50 basis points to 19.0%. – Net cash from operations increased to a record level of $990.3 million. – Adjusted earnings per share increased 14.6%. NET SALES ADJUSTED EARNINGS PER SHARE (in millions of dollars) (in dollars) 2018 $4,146 2018 $2.27 2019 $4,358 2019 $2.47(1) 2020 $4,8962020 $2.83(2) For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. * This annual report includes non-GAAP financial measures, including adjusted income from operations, adjusted operating profit margin, adjusted net income, adjusted EPS, organic sales, and free cash flow, which differ from reported results using Generally Accepted Accounting Principles (GAAP).
    [Show full text]
  • Showcase Savings Event!
    SHOWCASE SAVINGS EVENT! Save Friday, August 17 – Wednesday, August 29, 2018 NEW ULTRA MATTES BY COLOUR RICHE FRIZZY FREE* John Frieda Frizz Ease Leave-in Conditioner 236ml 979 (value up to $7.99) *With the purchase of 1 John Frieda Frizz Ease Shampoo and 977 1 Conditioner (excludes trial sizes). With in-store coupon. RICH NUDE SHADES ADDICTIVE POWDERY 99 MATTE FINISH 7each John Frieda Collection Haircare IN CONTROL 99 Sheer Blonde, Brilliant 6each Brunette, Frizz-Ease or Maria Borges wears the shade Bold Mauve 979. L’Oréal Paris Cosmetics Luxurious Volume. LOREALPARIS.CA Select prodcuts Select products HOT PRICE 99 2each Dove Products Select products 99 7each Neutrogena Select products 99 12 each Neutrogena Select products Rainchecks may not be available on some lyer merchandise. Expanded Ship to home All prices are shown before applicable tax. Provincial Electronics londondrugs.com selection or pick up in-store Recycling Environmental levy may apply on select items. A17_Showcase.indd 1 08/01/18 8:07:05 AM SHOWCASE SAVINGS EVENT BUY 2, GET 3rd FREE* SAVE With in-store coupon. % *Free product must be of 20 equal or lesser value than Of our everyday purchased products. low prices! NeoStrata Tweezerman Beauty Tools Skincare 99 3each Live Clean Liquid Hand Soap 500ml or Hand Wash 400ml 99 SAVE 4each % Live Clean Baby 20 Products, Of our everyday Liquid Soap low prices! Reill 1L, Haircare Certiied organic botanicals or Aveeno Skincare Products Body Wash 500ml 99 8each Banana Boat Suncare Select products BUY 2, GET 3rd 99 * 9each FREE Hawaiian Tropic With in-store coupon.
    [Show full text]
  • Annual Report Church & Dwight Co., Inc
    CHURCH & DWIGHT CO., INC. 2013 ANNUAL REPORT CO., CHURCH & DWIGHT ® CHUrcH & DWIGHT CO., INC. CHURCH & DWIGHT CO., INC. 2013 Princeton South Corporate Center 500 Charles Ewing Boulevard Ewing, NJ 08628 ANNUAL REPORT www.churchdwight.com FINANCIAL HIGHLIGHTS IN MILLIONS, EXCEPT PER SHARE DATA 2012 2013 net sales $ 2,922 $ 3,194 gross profit margin 44.2 % 45.0 % income from operations $ 545 $ 622 operating profit margin 18.7 % 19.5 % net income $ 350 $ 394 net income per share - diluted $ 2.45 $ 2.79 dividends per share $ 0.96 $ 1.12 year-end stock price $ 53.57 $ 66.28 2013 HIGHLIGHTS • Worldwide net sales increased 9.3%. • Adjusted net cash from operations increased to a record level of $536 million.(2) • Organic sales increased 1.9%.(1) • Earnings per share increased 13.9%. • Gross profit margin increased 80 basis points to 45.0%. • On January 29, 2014, the Company declared a 11% increase in its quarterly dividend from $0.28 share to • Operating profit margin increased 80 basis $0.31 share. points to 19.5%. NET SALES EARNINGS PER SHARE (in millions of dollars) (in dollars) , , . , . .* 2011* ADJUSTED FOR Tax Charge $0.09 2011 Reported EPS $2.12 ‘11 ‘12 ‘13 ‘11 ‘12 ‘13 For additional information, see Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. (1) The reference to the 1.9% organic net sales growth in 2013 reflects the following adjustments to the 9.3% reported on net sales growth: foreign currency exchange fluctuations +0.5% partially offset by acquisitions (7.6%) and sales in anticipation of ERP conversion (0.3%).
    [Show full text]